Sulfaperin

DB13320

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 264.3
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

113 Data
Nicotine The risk or severity of adverse effects can be increased when Sulfaperin is combined with Nicotine.
Mecamylamine The risk or severity of adverse effects can be increased when Sulfaperin is combined with Mecamylamine.
Pentolinium The risk or severity of adverse effects can be increased when Sulfaperin is combined with Pentolinium.
Trimethaphan The risk or severity of adverse effects can be increased when Sulfaperin is combined with Trimethaphan.
Hexamethonium The risk or severity of adverse effects can be increased when Sulfaperin is combined with Hexamethonium.
Cyclopentamine The risk or severity of adverse effects can be increased when Sulfaperin is combined with Cyclopentamine.
Methotrexate The protein binding of Methotrexate can be increased when combined with Sulfaperin.
Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfaperin.
Dexketoprofen The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Sulfaperin.
Cyclosporine The risk or severity of renal failure can be increased when Sulfaperin is combined with Cyclosporine.
Insulin human The risk or severity of hypoglycemia can be increased when Sulfaperin is combined with Insulin human.
Insulin lispro The risk or severity of hypoglycemia can be increased when Sulfaperin is combined with Insulin lispro.
Insulin glargine The risk or severity of hypoglycemia can be increased when Sulfaperin is combined with Insulin glargine.
Insulin pork The risk or severity of hypoglycemia can be increased when Sulfaperin is combined with Insulin pork.
Troglitazone The therapeutic efficacy of Troglitazone can be increased when used in combination with Sulfaperin.
Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulfaperin.
Sulfisoxazole The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Sulfaperin.
Disopyramide The therapeutic efficacy of Disopyramide can be increased when used in combination with Sulfaperin.
Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Sulfaperin.
Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Sulfaperin.
Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Sulfaperin.
Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Sulfaperin.
Acetohexamide The therapeutic efficacy of Acetohexamide can be increased when used in combination with Sulfaperin.
Quinine The therapeutic efficacy of Quinine can be increased when used in combination with Sulfaperin.
Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Sulfaperin.
Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Sulfaperin.
Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Sulfaperin.
Pentamidine The therapeutic efficacy of Pentamidine can be increased when used in combination with Sulfaperin.
Mifepristone The therapeutic efficacy of Mifepristone can be increased when used in combination with Sulfaperin.
Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Sulfaperin.
Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Sulfaperin.
Phenformin The therapeutic efficacy of Phenformin can be increased when used in combination with Sulfaperin.
Sulfamethoxazole The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Sulfaperin.
Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfaperin.
Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Sulfaperin.
Gliclazide The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulfaperin.
Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Sulfaperin.
Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Sulfaperin.
Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Sulfaperin.
Gliquidone The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulfaperin.
Mitiglinide The therapeutic efficacy of Mitiglinide can be increased when used in combination with Sulfaperin.
Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Sulfaperin.
Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Sulfaperin.
Exenatide The therapeutic efficacy of Exenatide can be increased when used in combination with Sulfaperin.
Mecasermin The therapeutic efficacy of Mecasermin can be increased when used in combination with Sulfaperin.
Pramlintide The therapeutic efficacy of Pramlintide can be increased when used in combination with Sulfaperin.
Glisoxepide The therapeutic efficacy of Glisoxepide can be increased when used in combination with Sulfaperin.
Insulin aspart The risk or severity of hypoglycemia can be increased when Sulfaperin is combined with Insulin aspart.
Insulin detemir The risk or severity of hypoglycemia can be increased when Sulfaperin is combined with Insulin detemir.
Insulin glulisine The risk or severity of hypoglycemia can be increased when Sulfaperin is combined with Insulin glulisine.
Glymidine The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfaperin.
AICA ribonucleotide The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Sulfaperin.
Buformin The therapeutic efficacy of Buformin can be increased when used in combination with Sulfaperin.
Vildagliptin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfaperin.
Voglibose The therapeutic efficacy of Voglibose can be increased when used in combination with Sulfaperin.
NN344 The risk or severity of hypoglycemia can be increased when Sulfaperin is combined with NN344.
AMG-222 The therapeutic efficacy of AMG-222 can be increased when used in combination with Sulfaperin.
Bisegliptin The therapeutic efficacy of Bisegliptin can be increased when used in combination with Sulfaperin.
Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Sulfaperin.
Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Sulfaperin.
Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Sulfaperin.
Liraglutide The therapeutic efficacy of Liraglutide can be increased when used in combination with Sulfaperin.
Gosogliptin The therapeutic efficacy of Gosogliptin can be increased when used in combination with Sulfaperin.
Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Sulfaperin.
Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfaperin.
Glibornuride The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfaperin.
Benfluorex The therapeutic efficacy of Benfluorex can be increased when used in combination with Sulfaperin.
Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Sulfaperin.
Albiglutide The therapeutic efficacy of Albiglutide can be increased when used in combination with Sulfaperin.
Dulaglutide The therapeutic efficacy of Dulaglutide can be increased when used in combination with Sulfaperin.
Lobeglitazone The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Sulfaperin.
Netoglitazone The therapeutic efficacy of Netoglitazone can be increased when used in combination with Sulfaperin.
Rivoglitazone The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Sulfaperin.
Ciglitazone The therapeutic efficacy of Ciglitazone can be increased when used in combination with Sulfaperin.
Lixisenatide The therapeutic efficacy of Lixisenatide can be increased when used in combination with Sulfaperin.
Insulin beef The risk or severity of hypoglycemia can be increased when Sulfaperin is combined with Insulin beef.
Insulin degludec The risk or severity of hypoglycemia can be increased when Sulfaperin is combined with Insulin degludec.
Insulin peglispro The risk or severity of hypoglycemia can be increased when Sulfaperin is combined with Insulin peglispro.
Insulin tregopil The risk or severity of hypoglycemia can be increased when Sulfaperin is combined with Insulin tregopil.
Ipragliflozin The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Sulfaperin.
Dutogliptin The therapeutic efficacy of Dutogliptin can be increased when used in combination with Sulfaperin.
Allicin The therapeutic efficacy of Allicin can be increased when used in combination with Sulfaperin.
Tofogliflozin The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Sulfaperin.
Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Sulfaperin.
2,4-thiazolidinedione The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Sulfaperin.
Teneligliptin The therapeutic efficacy of Teneligliptin can be increased when used in combination with Sulfaperin.
Omarigliptin The therapeutic efficacy of Omarigliptin can be increased when used in combination with Sulfaperin.
Carmegliptin The therapeutic efficacy of Carmegliptin can be increased when used in combination with Sulfaperin.
Gemigliptin The therapeutic efficacy of Gemigliptin can be increased when used in combination with Sulfaperin.
Anagliptin The therapeutic efficacy of Anagliptin can be increased when used in combination with Sulfaperin.
Evogliptin The therapeutic efficacy of Evogliptin can be increased when used in combination with Sulfaperin.
Sotagliflozin The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Sulfaperin.
Balaglitazone The therapeutic efficacy of Balaglitazone can be increased when used in combination with Sulfaperin.
Remogliflozin etabonate The therapeutic efficacy of Remogliflozin etabonate can be increased when used in combination with Sulfaperin.
Carbutamide The therapeutic efficacy of Carbutamide can be increased when used in combination with Sulfaperin.
Guar gum The therapeutic efficacy of Guar gum can be increased when used in combination with Sulfaperin.
Metahexamide The therapeutic efficacy of Metahexamide can be increased when used in combination with Sulfaperin.
Semaglutide The therapeutic efficacy of Semaglutide can be increased when used in combination with Sulfaperin.
Taspoglutide The therapeutic efficacy of Taspoglutide can be increased when used in combination with Sulfaperin.
Englitazone The therapeutic efficacy of Englitazone can be increased when used in combination with Sulfaperin.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul